Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juha Laine

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 7, 2015
[Cost-effectiveness alone is not sufficient as basis for prioritization]Juha Laine
Health Care Management Review|February 24, 2006
RUG-III for exploring the association between staffing levels and cost-efficiency in nursing facility care in FinlandJuha Laine
Clinical Ophthalmology (Auckland, N.Z.)|December 16, 2024
Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest FinlandHanna Heloterä, Anna-Mari Viita, Juha Laine
Health Care Management Science|June 15, 2005
The cost efficiency and clinical quality of institutional long-term care for the elderlyJuha Laine, Miika Linna, Anja Noro, et al.
Health Economics|September 24, 2004
Measuring the productive efficiency and clinical quality of institutional long-term care for the elderlyJuha Laine, Miika Linna, Unto Häkkinen, et al.
Journal of Health Services Research & Policy|November 2, 2005
Patient- and ward-level determinants of nursing time in nursing facilitiesJuha Laine, Anja Noro, Harriet Finne-Soveri, et al.
Current Medical Research and Opinion|November 27, 2008
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*Klaus Tamminen, Juha Laine, Erkki Soini, et al.
Health Economics Review|April 11, 2025
Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50-69 to 45 and/or 74: A cohort modelling study in the Finnish settingFilip Siegfrids, Sirpa Heinävaara, Tytti Sarkeala, et al.
Biologics : Targets & Therapy|April 22, 2016
Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockersJuha Laine, T Sakari Jokiranta, Kari K Eklund, et al.
Current Medical Research and Opinion|August 18, 2018
Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patientsMiika Linna, Juha Laine, Leena Timonen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|January 7, 2015
[Cost-effectiveness alone is not sufficient as basis for prioritization]Juha Laine
Health Care Management Review|February 24, 2006
RUG-III for exploring the association between staffing levels and cost-efficiency in nursing facility care in FinlandJuha Laine
Clinical Ophthalmology (Auckland, N.Z.)|December 16, 2024
Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest FinlandHanna Heloterä, Anna-Mari Viita, Juha Laine
Health Care Management Science|June 15, 2005
The cost efficiency and clinical quality of institutional long-term care for the elderlyJuha Laine, Miika Linna, Anja Noro, et al.
Health Economics|September 24, 2004
Measuring the productive efficiency and clinical quality of institutional long-term care for the elderlyJuha Laine, Miika Linna, Unto Häkkinen, et al.
Journal of Health Services Research & Policy|November 2, 2005
Patient- and ward-level determinants of nursing time in nursing facilitiesJuha Laine, Anja Noro, Harriet Finne-Soveri, et al.
Current Medical Research and Opinion|November 27, 2008
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*Klaus Tamminen, Juha Laine, Erkki Soini, et al.
Health Economics Review|April 11, 2025
Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50-69 to 45 and/or 74: A cohort modelling study in the Finnish settingFilip Siegfrids, Sirpa Heinävaara, Tytti Sarkeala, et al.
Biologics : Targets & Therapy|April 22, 2016
Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockersJuha Laine, T Sakari Jokiranta, Kari K Eklund, et al.
Current Medical Research and Opinion|August 18, 2018
Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patientsMiika Linna, Juha Laine, Leena Timonen, et al.
Pageof 2